Cite
HARVARD Citation
Gossec, L. et al. (n.d.). SAT0463 Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through 3 years: long-term data from the future 1 and future 2 studies. Annals of the rheumatic diseases. p. 949. [Online].